These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 12176497)

  • 1. Comparison of the therapeutic effects between CsA and FK506 on chronic renal allograft injury and TGF-beta expression.
    Miyagi M; Muramatsu M; Ishikawa Y; Ishii T; Sakai K; Arai K; Aikawa A; Ohara T; Mizuiri M; Hirayama N; Hasegawa A
    Transplant Proc; 2002 Aug; 34(5):1589-90. PubMed ID: 12176497
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of leflunomide analogue FK778 on development of chronic rat renal allograft rejection and transforming growth factor-BETA expression.
    Rintala JM; Savikko J; Rintala SE; von Willebrand E
    Transplant Proc; 2006 Dec; 38(10):3239-40. PubMed ID: 17175234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Active TGF-beta1 expression in kidney transplantation: a comparative study of cyclosporin-A (CyA) and tacrolimus (FK506).
    Mohamed MA; Robertson H; Booth TA; Balupuri S; Gerstenkorn C; Kirby JA; Talbot D
    Transpl Int; 2000; 13 Suppl 1():S295-8. PubMed ID: 11112017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TGF-beta expression in renal transplant biopsies: a comparative study between cyclosporin-A and tacrolimus.
    Mohamed MA; Robertson H; Booth TA; Balupuri S; Kirby JA; Talbot D
    Transplantation; 2000 Mar; 69(5):1002-5. PubMed ID: 10755567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FK506 "rescue" therapy complicated by renal tubular acidosis in renal allograft recipients.
    Goh BL; Tan SY
    Transplant Proc; 1998 Nov; 30(7):3594-5. PubMed ID: 9838575
    [No Abstract]   [Full Text] [Related]  

  • 6. FK778 ameliorates post-transplant expression of fibrogenic growth factors and development of chronic rejection changes in rat kidney allografts.
    Rintala JM; Savikko J; Rintala SE; von Willebrand E
    Nephrol Dial Transplant; 2008 Nov; 23(11):3446-55. PubMed ID: 18558624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conversion from cyclosporine to tacrolimus for chronic allograft nephropathy.
    Ji SM; Li LS; Sha GZ; Chen JS; Liu ZH
    Transplant Proc; 2007 Jun; 39(5):1402-5. PubMed ID: 17580148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative study of clinicopathologic characteristics of renal allografts under cyclosporine and FK506 immunosuppression.
    Sugito K; Morozumi K; Oikawa T
    Transplant Proc; 1996 Jun; 28(3):1335-7. PubMed ID: 8658683
    [No Abstract]   [Full Text] [Related]  

  • 9. Five-year experience with tacrolimus rescue for renal allograft rejection.
    Jordan ML; Naraghi RN; Shapiro R; Smith D; Vivas CA; Scantlebury VP; Gritsch HA; McCauley J; Randhawa P; Demetris AJ; McMichael J; Fung JJ; Starzl TE
    Transplant Proc; 1997; 29(1-2):306. PubMed ID: 9123009
    [No Abstract]   [Full Text] [Related]  

  • 10. The effects of different immunosuppressants on chronic allograft nephropathy by affecting the transforming growth factor-beta and Smads signal pathways.
    Gao R; Lu Y; Xin YP; Zhang XH; Wang J; Li YP
    Transplant Proc; 2006 Sep; 38(7):2154-7. PubMed ID: 16980029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FK506 and CsA differ in their effect on intracellular cytokine expression following kidney transplantation.
    Zamauskaite A; Cohen S; Sweny P; Madrigal A; Varghese Z; McLean A; Powis SH
    Transplant Proc; 2001; 33(1-2):1046-7. PubMed ID: 11267184
    [No Abstract]   [Full Text] [Related]  

  • 12. Primary immunosuppression with tacrolimus is associated with a reduction in renal allograft fibrosis compared with neoral therapy.
    Waller JR; Murphy GJ; Metcalfe MS; Sandford RM; Pattenden CJ; Nicholson ML
    Transplant Proc; 2002 Aug; 34(5):1587-8. PubMed ID: 12176496
    [No Abstract]   [Full Text] [Related]  

  • 13. Is TGF-beta a profibrotic cytokine in human renal transplants?
    Nicholson ML; Bicknell GR; Williams ST; Furness PN
    Transplant Proc; 1998 Jun; 30(4):952. PubMed ID: 9636384
    [No Abstract]   [Full Text] [Related]  

  • 14. A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group.
    Pirsch JD; Miller J; Deierhoi MH; Vincenti F; Filo RS
    Transplantation; 1997 Apr; 63(7):977-83. PubMed ID: 9112351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of acute rejection on expression of fibrosis associated genes in renal transplant recipients.
    White SA; Bicknell GR; Jain S; Williams ST; Doughman T; Furness P; Nicholson ML
    Transplant Proc; 2000 Feb; 32(1):19-20. PubMed ID: 10700949
    [No Abstract]   [Full Text] [Related]  

  • 16. Molecular and structural consequences of early renal allograft injury.
    Baboolal K; Jones GA; Janezic A; Griffiths DR; Jurewicz WA
    Kidney Int; 2002 Feb; 61(2):686-96. PubMed ID: 11849412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FK506 rescue therapy for acute renal allograft rejection.
    Goh BL; Morad Z; Cheah PL; Chua CT; Tan SY
    Transplant Proc; 1998 Nov; 30(7):3592-3. PubMed ID: 9838574
    [No Abstract]   [Full Text] [Related]  

  • 18. Conversion from cyclosporine to tacrolimus prevents transplant function loss due to acute steroid-resistant or chronic rejection in renal allograft recipients.
    Blume C; Hollenbeck M; Ivens K; Heering P; Hetzel GR; Grabensee B
    Transplant Proc; 2001; 33(7-8):3161-3. PubMed ID: 11750357
    [No Abstract]   [Full Text] [Related]  

  • 19. Conversion from cyclosporine to tacrolimus in renal allograft recipients with delayed graft function from severe acute tubular necrosis.
    Jang HJ; Kim SC; Han DJ
    Transplant Proc; 2000 Nov; 32(7):1714-5. PubMed ID: 11119904
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of tacrolimus and cyclosporin in renal transplantation by the protocol biopsies.
    Töz H; Sen S; Seziş M; Duman S; Ozkahya M; Ozbek S; Hoşcoşkun C; Atabay G; Ok E
    Transplant Proc; 2004; 36(1):134-6. PubMed ID: 15013324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.